Caffeine: Difference between revisions
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Expand stub to full MedTemplate parameter set |
MDElliottMD (talk | contribs) Recategorize: Stimulants -> Psychostimulants |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 8: | Line 8: | ||
| starting_dose = | | starting_dose = | ||
| preparations = | | preparations = | ||
| fda_max = | |||
| routes = | | routes = | ||
| onset = | | onset = | ||
| Line 21: | Line 22: | ||
| dosing = | | dosing = | ||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 29: | Line 29: | ||
| seealso = | | seealso = | ||
| references = | | references = | ||
}} | |||
{{PendellsCorner | |||
| quote = Caffeine is a central nervous system stimulant, a cardiac stimulant, a respiratory stimulant, and a diuretic. Caffeine is addictive. Withdrawal symptoms typically include irritability, fatigue, and headaches, sometimes severe. | |||
| volume = Dynamis | |||
| page = 29 | |||
}} | }} | ||
[[Category:Psychostimulants]] | [[Category:Psychostimulants]] | ||
[[Category:Xanthines]] | |||
[[Category:Psychostimulants]] | |||
Latest revision as of 10:50, 17 May 2026
Xanthine, Stimulant
Caffeine
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
Pharmacogenomic + mechanism interactions
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
FDA Drug Interactions Table: sensitive index substrate of CYP1A2.
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice?trivialcritical
Mechanism description, if it needs work:
Is this row worth surfacing?
Your own experience with this combination:
Experience (1 a little, 5 a lot)
Outcome (-100 worst, +100 best)
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Fluvoxamine inhibits CYP1A2 (inhibitor_strong, intensity 90); Caffeine is a substrate_major of CYP1A2 (intensity 80). Derived: Caffeine exposure raised.
Inferred via Enzyme:CYP1A2 (exposure raised)
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice?trivialcritical
Confidence in this inference: is the inferred magnitude sound?overstatedsound
Mechanism description, if it needs work:
Is this row worth surfacing?
Your own experience with this combination:
Experience (1 a little, 5 a lot)
Outcome (-100 worst, +100 best)
Patient experience
No patient-experience reports yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Xanthine, Stimulant
Common uses
Pharmacy
Pharmacology
Purported mechanism
Adenosine receptor antagonist
“Pendell's corner
Caffeine is a central nervous system stimulant, a cardiac stimulant, a respiratory stimulant, and a diuretic. Caffeine is addictive. Withdrawal symptoms typically include irritability, fatigue, and headaches, sometimes severe.
— Dale Pendell, Pharmako/Dynamis, p. 29